Medically reviewed by Drugs.com. Last updated on May 11, 2021.
Aclidinium Levels and Effects while Breastfeeding
Summary of Use during Lactation
Although no published data exist on the use of aclidinium during breastfeeding, it produces low maternal serum levels because of rapid hydrolysis to inactive metabolites. The risk to the breastfed infant of maternal aclidinium inhalation is small.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Substance Identification
Substance Name
Aclidinium
CAS Registry Number
727649-81-2
Drug Class
-
Breast Feeding
-
Lactation
-
Anti-Asthmatic Agents
-
Parasympatholytics
-
Muscarinic Antagonists
-
Bronchodilator Agents
-
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
